Mohamed Ben Hassel
Overview
Explore the profile of Mohamed Ben Hassel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
1364
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein M, Drijver A, van den Bent M, Bromberg J, Hoang-Xuan K, Taphoorn M, et al.
Neuro Oncol
. 2020 Nov;
23(5):803-811.
PMID: 33130890
Background: EORTC study 22033-26033 showed no difference in progression-free survival between high-risk low-grade glioma receiving either radiotherapy (RT) or temozolomide (TMZ) chemotherapy alone as primary treatment. Considering the potential long-term...
2.
Baumert B, Hegi M, van den Bent M, von Deimling A, Gorlia T, Hoang-Xuan K, et al.
Lancet Oncol
. 2016 Oct;
17(11):1521-1532.
PMID: 27686946
Background: Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting molecular heterogeneity of the disease. We compared two different, single-modality treatment strategies of standard radiotherapy versus primary temozolomide...
3.
Reijneveld J, Taphoorn M, Coens C, Bromberg J, Mason W, Hoang-Xuan K, et al.
Lancet Oncol
. 2016 Oct;
17(11):1533-1542.
PMID: 27686943
Background: Temozolomide chemotherapy versus radiotherapy in patients with a high-risk low-grade glioma has been shown to have no significant effect on progression-free survival. If these treatments have a different effect...
4.
Soffietti R, Kocher M, Abacioglu U, Villa S, Fauchon F, Baumert B, et al.
J Clin Oncol
. 2012 Dec;
31(1):65-72.
PMID: 23213105
Purpose: This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with observation after either surgery or radiosurgery of a limited number of brain metastases in patients with stable solid tumors....
5.
Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert B, et al.
J Clin Oncol
. 2010 Nov;
29(2):134-41.
PMID: 21041710
Purpose: This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of...
6.
Lesimple T, Riffaud L, Frappaz D, Ben Hassel M, Gedouin D, Bay J, et al.
J Neurooncol
. 2009 Jan;
93(2):253-60.
PMID: 19139825
Improving glioblastoma multiforme (GBM) treatment with radio-chemotherapy remains a challenge. Topotecan is an attractive option as it exhibits growth inhibition of human glioma as well as brain penetration. The present...
7.
Frappaz D, Chinot O, Bataillard A, Ben Hassel M, Capelle L, Chanalet S, et al.
Bull Cancer
. 2004 Jan;
90(10):873-86.
PMID: 14706916
Context: The "Standards, Options and Recommendations" (SOR) project, which started in 1993, is a collaboration between the Federation of French Cancer Centers (FNCLCC), the 20 French Regional Cancer Centers, and...